PT67662B - Process for the preparation of substituted ureas - Google Patents

Process for the preparation of substituted ureas

Info

Publication number
PT67662B
PT67662B PT67662A PT6766278A PT67662B PT 67662 B PT67662 B PT 67662B PT 67662 A PT67662 A PT 67662A PT 6766278 A PT6766278 A PT 6766278A PT 67662 B PT67662 B PT 67662B
Authority
PT
Portugal
Prior art keywords
preparation
substituted ureas
ureas
substituted
Prior art date
Application number
PT67662A
Other languages
English (en)
Other versions
PT67662A (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PT67662A publication Critical patent/PT67662A/pt
Publication of PT67662B publication Critical patent/PT67662B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/22—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT67662A 1977-02-17 1978-02-16 Process for the preparation of substituted ureas PT67662B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/769,475 US4144338A (en) 1977-02-17 1977-02-17 N-pyrimidinyl-N-dialkylaminoalkyl ureas

Publications (2)

Publication Number Publication Date
PT67662A PT67662A (en) 1978-03-01
PT67662B true PT67662B (en) 1980-03-03

Family

ID=25085546

Family Applications (1)

Application Number Title Priority Date Filing Date
PT67662A PT67662B (en) 1977-02-17 1978-02-16 Process for the preparation of substituted ureas

Country Status (8)

Country Link
US (1) US4144338A (pt)
JP (1) JPS53103481A (pt)
DE (1) DE2806661A1 (pt)
ES (1) ES466844A1 (pt)
FR (1) FR2381035A1 (pt)
GB (1) GB1569517A (pt)
NL (1) NL7801064A (pt)
PT (1) PT67662B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215121A (en) * 1977-02-17 1980-07-29 Merck & Co., Inc. Pyrazine substituted ureas
US4226871A (en) * 1979-03-13 1980-10-07 Merck & Co., Inc. Heterocyclic carbamates
US4415575A (en) * 1979-03-13 1983-11-15 Merck & Co., Inc. Suppression of gastric acid secretion using pyrimidylcarbamates
US4235802A (en) * 1979-08-14 1980-11-25 E. I. Du Pont De Nemours And Company Propenimidates
US4619686A (en) * 1984-07-17 1986-10-28 Eli Lilly And Company Pyridazinylurea compounds and methods of use as herbicides
DE3531658A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel
JPH0720943B2 (ja) * 1988-08-19 1995-03-08 宇部興産株式会社 アミノピリミジン誘導体、その製法及び殺虫・殺菌剤
DE4131924A1 (de) * 1991-09-25 1993-07-08 Hoechst Ag Substituierte 4-alkoxypyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
WO2003077656A1 (en) * 2002-03-15 2003-09-25 Ciba Specialty Chemicals Holding Inc. 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759921A (en) * 1969-10-16 1973-09-18 Lilly Co Eli Method of suppressing immuneresponse with 1 substituted-3-(2 pyrimidyl)ureas
US3705159A (en) * 1970-03-05 1972-12-05 Sandoz Ltd Herbicidal 2,4-di(substituted) amino-6-chloro pyrimidines
US3950537A (en) * 1973-06-29 1976-04-13 Rohm And Haas Company Gastrointestinally active thioureas
US4008235A (en) * 1975-03-07 1977-02-15 Sterling Drug Inc. N-[2-(pyridinyl)-4-pyrimidinyl]ureas

Also Published As

Publication number Publication date
PT67662A (en) 1978-03-01
JPS53103481A (en) 1978-09-08
ES466844A1 (es) 1979-08-16
NL7801064A (nl) 1978-08-21
GB1569517A (en) 1980-06-18
FR2381035A1 (fr) 1978-09-15
DE2806661A1 (de) 1978-08-31
US4144338A (en) 1979-03-13

Similar Documents

Publication Publication Date Title
PT68294A (en) Process for the preparation of substituted naphthyridinones
GB2006772B (en) Process for the preparation of an amine
DE2860898D1 (en) Process for the preparation of triarylphosphites
GR64790B (en) Method for the preparation of novel 4-acylamine-phenyl-ethanolamine
GB2006773B (en) Process for the preparation of an amine
GB2006212B (en) Process for the preparation of d(-)-a-phenylglycine
IL55819A (en) Process for the preparation of o-methallyloxyphenol
PT67662A (en) Process for the preparation of substituted ureas
PT68840A (en) Process for the preparation of 3-iodo-and bromorifamycin
NZ187621A (en) Process for preparation of 1-substituted benzoyl-3-aryl ureas
ZA784416B (en) Process for the preparation of hydroxyphenylhydantoin
GB2009151B (en) Process for the manufacture of substituted dihydrocinnamaldehydes
IL53553A0 (en) Process for the preparation of hydroxy-alpha-amino-benzyl penicillin
PT68486A (en) Improved process for the preparation of 2-clorosulfinila zeditin-4-onas
DE2860663D1 (en) Process for the preparation of formaldehyde
GB2001957B (en) Process for the preparation of 2-alkoxy-tetrahydrofurans
GB2006764B (en) Process for the preparation of 4-chloroquinolines
GB2006200B (en) Process for the preparation of amines
DE2860746D1 (en) Process for the preparation of 3-bromomethyl-3-cephem-sulphoxide derivatives
DE2860809D1 (en) Process for the preparation of 3-pyridazinones
IL54372A (en) Process for the preparation of d thiazolidine-azetidinone
ZA785651B (en) Process for the preparation of(-)-vincamine
PT68882A (en) Process for the preparation of imino-bridged benzocycloheptapyridines
DE2860619D1 (en) Process for the preparation of morpholino-dithiothiazoles
GB2007667B (en) Process for the preparation of ss-lactam compounds